{"schema_version":"secwatch.filing_event.v1","accession":"0000813672-22-000044","form_type":"8-K","ticker":"CDNS","cik":"0000813672","company_name":"CADENCE DESIGN SYSTEMS INC","filed_at":"2022-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.210766+00:00","generated_at":"2026-06-23T18:12:28.431825+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cadence completes acquisition of OpenEye Scientific Software for drug discovery software","bullets":["Acquisition of OpenEye Scientific Software closed on August 31, 2022.","OpenEye provides computational molecular modeling and simulation software for drug discovery.","Funded by cash on hand and borrowings under Cadence's senior unsecured revolving credit facility.","No purchase price or financial guidance disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000813672-22-000044","json":"https://secwatch.observer/filing/0000813672-22-000044.json","markdown":"https://secwatch.observer/filing/0000813672-22-000044.md","text":"https://secwatch.observer/filing/0000813672-22-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/813672/000081367222000044/0000813672-22-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/813672/000081367222000044/cdns-20220831.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T18:12:28.431825+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}